228 related articles for article (PubMed ID: 17522229)
21. Adaptive mutation F772S-enhanced p7-NS4A cooperation facilitates the assembly and release of hepatitis C virus and is associated with lipid droplet enlargement.
Duan X; Anwar MI; Xu Z; Ma L; Yuan G; Chen Y; Liu X; Xia J; Zhou Y; Li YP
Emerg Microbes Infect; 2018 Aug; 7(1):143. PubMed ID: 30087320
[TBL] [Abstract][Full Text] [Related]
22. Structure and function analysis of the essential 3'X domain of hepatitis C virus.
Castillo-Martínez J; Ovejero T; Romero-López C; Sanmartín I; Berzal-Herranz B; Oltra E; Berzal-Herranz A; Gallego J
RNA; 2020 Feb; 26(2):186-198. PubMed ID: 31694875
[TBL] [Abstract][Full Text] [Related]
23. An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain.
Date T; Miyamoto M; Kato T; Morikawa K; Murayama A; Akazawa D; Tanabe J; Sone S; Mizokami M; Wakita T
Hepatol Res; 2007 Jun; 37(6):433-43. PubMed ID: 17437527
[TBL] [Abstract][Full Text] [Related]
24. HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A.
Abe K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
Arch Virol; 2009; 154(10):1671-7. PubMed ID: 19779801
[TBL] [Abstract][Full Text] [Related]
25. Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication.
Goh PY; Tan YJ; Lim SP; Tan YH; Lim SG; Fuller-Pace F; Hong W
J Virol; 2004 May; 78(10):5288-98. PubMed ID: 15113910
[TBL] [Abstract][Full Text] [Related]
26. Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone.
Chandra PK; Hazari S; Poat B; Gunduz F; Prabhu R; Liu G; Burioni R; Clementi M; Garry RF; Dash S
Virol J; 2010 Jun; 7():118. PubMed ID: 20529250
[TBL] [Abstract][Full Text] [Related]
27. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
[TBL] [Abstract][Full Text] [Related]
28. PPP2R5D promotes hepatitis C virus infection by binding to viral NS5B and enhancing viral RNA replication.
Anwar MI; Li N; Zhou Q; Chen M; Hu C; Wu T; Chen H; Li YP; Zhou Y
Virol J; 2022 Jul; 19(1):118. PubMed ID: 35836293
[TBL] [Abstract][Full Text] [Related]
29. Form confers function: Case of the 3'X region of the hepatitis C virus genome.
Dutkiewicz M; Ciesiołka J
World J Gastroenterol; 2018 Aug; 24(30):3374-3383. PubMed ID: 30122877
[TBL] [Abstract][Full Text] [Related]
30. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
[TBL] [Abstract][Full Text] [Related]
31. Superinfection exclusion in cells infected with hepatitis C virus.
Tscherne DM; Evans MJ; von Hahn T; Jones CT; Stamataki Z; McKeating JA; Lindenbach BD; Rice CM
J Virol; 2007 Apr; 81(8):3693-703. PubMed ID: 17287280
[TBL] [Abstract][Full Text] [Related]
32. Replication and infectivity of a novel genotype 1b hepatitis C virus clone.
Date T; Morikawa K; Tanaka Y; Tanaka-Kaneko K; Sata T; Mizokami M; Wakita T
Microbiol Immunol; 2012 May; 56(5):308-17. PubMed ID: 22320232
[TBL] [Abstract][Full Text] [Related]
33. Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein.
Vogt DA; Camus G; Herker E; Webster BR; Tsou CL; Greene WC; Yen TS; Ott M
PLoS Pathog; 2013; 9(4):e1003302. PubMed ID: 23593007
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of HCV replication by oxysterol-binding protein-related protein 4 (ORP4) through interaction with HCV NS5B and alteration of lipid droplet formation.
Park IW; Ndjomou J; Wen Y; Liu Z; Ridgway ND; Kao CC; He JJ
PLoS One; 2013; 8(9):e75648. PubMed ID: 24069433
[TBL] [Abstract][Full Text] [Related]
35. Production of infectious hepatitis C virus of various genotypes in cell cultures.
Kato T; Matsumura T; Heller T; Saito S; Sapp RK; Murthy K; Wakita T; Liang TJ
J Virol; 2007 May; 81(9):4405-11. PubMed ID: 17301131
[TBL] [Abstract][Full Text] [Related]
36. Novel nucleotide and amino acid covariation between the 5'UTR and the NS2/NS3 proteins of hepatitis C virus: bioinformatic and functional analyses.
Sun HY; Ou NY; Wang SW; Liu WC; Cheng TF; Shr SJ; Sun KT; Chang TT; Young KC
PLoS One; 2011; 6(9):e25530. PubMed ID: 21980483
[TBL] [Abstract][Full Text] [Related]
37. Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.
Qing J; Luo R; Wang Y; Nong J; Wu M; Shao Y; Tang R; Yu X; Yin Z; Sun Y
Antiviral Res; 2016 Feb; 126():43-54. PubMed ID: 26724382
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus 3'X region interacts with human ribosomal proteins.
Wood J; Frederickson RM; Fields S; Patel AH
J Virol; 2001 Feb; 75(3):1348-58. PubMed ID: 11152508
[TBL] [Abstract][Full Text] [Related]
39. A conserved proline between domains II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly.
Hughes M; Gretton S; Shelton H; Brown DD; McCormick CJ; Angus AG; Patel AH; Griffin S; Harris M
J Virol; 2009 Oct; 83(20):10788-96. PubMed ID: 19656877
[TBL] [Abstract][Full Text] [Related]
40. A novel strategy to develop a robust infectious hepatitis C virus cell culture system directly from a clinical isolate.
Lu J; Xiang Y; Tao W; Li Q; Wang N; Gao Y; Xiang X; Xie Q; Zhong J
J Virol; 2014 Feb; 88(3):1484-91. PubMed ID: 24227861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
